Physician profile
Robert T Pyo
NPI 1417997867
$60,630.72
in general payments reported to CMS, 2019-2025
31 companies · $5,609 in 2025
The $5,609 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,822 · 2020: $2,912 · 2021: $6,097 · 2022: $6,321 · 2023: $17K · 2024: $18K · 2025: $5,609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Food and Beverage: $12K · Honoraria: $7,200 · Travel and Lodging: $4,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,500.00 |
| Food and Beverage | $11,577.29 |
| Honoraria | $7,200.00 |
| Travel and Lodging | $4,200.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22,518.49 | 2019-2025 | Avvigo Guidance System, General - Therapies, Rotapro |
| Abiomed | $16,135.60 | 2019-2025 | Impella |
| Abbott Laboratories | $7,690.95 | 2019-2025 | Triclip, Mitraclip, Aveir |
| Medtronic, INC. | $4,477.03 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Hawkone |
| Medtronic Vascular, INC. | $4,082.03 | 2019-2020 | |
| Shockwave Medical, INC | $1,200.43 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Spectrawave, INC | $1,103.53 | 2023-2025 | Hypervue Imaging System, Starlight Imaging Catheter |
| Edwards Lifesciences Corporation | $723.54 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia |
| Saranas, INC. | $459.48 | 2022-2023 | |
| Philips North America LLC | $448.54 | 2019-2025 | Coronary Other, Visions 014 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $320.38 | 2019-2024 | Lifevest |
| Kestra Medical Technology Services, INC. | $273.86 | 2025 | Assure Wcd |
| Recor Medical INC | $212.24 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Terumo Medical Corporation | $195.17 | 2024-2025 | Glidesheath Slender, Heartrail |
| Endotronix, INC. | $179.70 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collaborative Care Diagnostics, LLC | $130.65 | 2025 | |
| Cardinal Health 200 LLC | $88.75 | 2019-2021 | |
| Penumbra, INC. | $57.42 | 2019-2022 | |
| Chiesi USA, INC. | $55.25 | 2020-2022 | |
| Amgen INC. | $44.53 | 2022 | |
| Novartis Pharmaceuticals Corporation | $40.16 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $32.50 | 2019 | |
| Argon Medical Devices, INC. | $25.59 | 2025 | Clot Management |
| Acist Medical Systems, INC. | $23.62 | 2022 | |
| Vifor Pharma, INC. | $23.35 | 2024 | Veltassa |
| Procyrion, INC. | $20.34 | 2024 | |
| Pfizer INC. | $19.94 | 2022 | |
| Cardiva Medical, INC. | $14.47 | 2022 | |
| Portola Pharmaceuticals, LLC | $13.77 | 2020 | |
| Teleflex LLC | $11.74 | 2022 | |
| Cardiovascular Systems INC. | $7.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pyo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.